See also this year's filing and all EDGAR filings for this company.
PDF Report 0001461993_2018_Melinta_Therapeutics_INC_NEW.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001461993, Melinta Therapeutics INC NEW
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 149,764,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 7,500,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,596,000 |
| 3 | remainder_Assets | 1,413,000 |
| 4 | LiabilitiesCurrent | 31,730,000 |
| 5 | LiabilitiesNoncurrent | 56,207,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 46,442,497 |
| 9 | ResearchAndDevelopmentExpense | 53,826,188 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 51,881,166 |
| 12 | remainder_NetIncome | 21,529,753 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 160,273,000 |
| 1 | Liabilities | 87,937,000 |
| 2 | Expenses | 100,268,685 |
| 3 | Revenues | 51,881,166 |
| 4 | StockholdersEquity | 72,336,000 |
| 5 | NetIncome | -26,857,766 |
| 6 | ComprehensiveNetIncome | -26,857,766 |
| 7 | BaseVar | 210,944,802 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.05 |
| 9 | EconomicCapitalRatio | 2.34 |
Edgar->Model Mapping
Feature Distribution
Change over Time
